Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of EUR 130.52 billion. The enterprise value is 141.23 billion.

Market Cap	130.52B
Enterprise Value	141.23B

Important Dates

The last earnings date was Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	May 13, 2024

Share Statistics

Sanofi has 1.25 billion shares outstanding. The number of shares has decreased by -0.02% in one year.

Current Share Class	n/a
Shares Outstanding	1.25B
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	57.63%
Float	1.13B

Valuation Ratios

The trailing PE ratio is 23.72 and the forward PE ratio is 12.67. Sanofi's PEG ratio is 1.23.

PE Ratio	23.72
Forward PE	12.67
PS Ratio	2.94
PB Ratio	1.68
P/TBV Ratio	6.57
P/FCF Ratio	22.18
P/OCF Ratio	n/a
PEG Ratio	1.23

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.73, with an EV/FCF ratio of 23.99.

EV / Earnings	25.40
EV / Sales	3.19
EV / EBITDA	11.73
EV / EBIT	15.82
EV / FCF	23.99

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.

Current Ratio	1.46
Quick Ratio	0.62
Debt / Equity	0.23
Debt / EBITDA	1.50
Debt / FCF	3.04
Interest Coverage	13.84

Financial Efficiency

Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 5.88%.

Return on Equity (ROE)	7.30%
Return on Assets (ROA)	4.28%
Return on Invested Capital (ROIC)	5.88%
Return on Capital Employed (ROCE)	8.56%
Revenue Per Employee	534,352
Profits Per Employee	67,087
Employee Count	82,878
Asset Turnover	0.34
Inventory Turnover	1.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.50% in the last 52 weeks. The beta is 0.46, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+19.50%
50-Day Moving Average	98.05
200-Day Moving Average	96.24
Relative Strength Index (RSI)	62.24
Average Volume (20 Days)	1,749,008

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of EUR 44.29 billion and earned 5.56 billion in profits. Earnings per share was 4.44.

Revenue	44.29B
Gross Profit	31.09B
Operating Income	8.87B
Pretax Income	6.76B
Net Income	5.56B
EBITDA	11.66B
EBIT	8.87B
Earnings Per Share (EPS)	4.44

Full Income Statement

Balance Sheet

The company has 7.56 billion in cash and 17.91 billion in debt, giving a net cash position of -10.36 billion or -8.26 per share.

Cash & Cash Equivalents	7.56B
Total Debt	17.91B
Net Cash	-10.36B
Net Cash Per Share	-8.26
Equity (Book Value)	77.86B
Book Value Per Share	61.83
Working Capital	13.43B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.08 billion and capital expenditures -3.20 billion, giving a free cash flow of 5.89 billion.

Operating Cash Flow	9.08B
Capital Expenditures	-3.20B
Free Cash Flow	5.89B
FCF Per Share	4.70

Full Cash Flow Statement

Margins

Gross margin is 70.21%, with operating and profit margins of 20.03% and 12.55%.

Gross Margin	70.21%
Operating Margin	20.03%
Pretax Margin	15.26%
Profit Margin	12.55%
EBITDA Margin	26.34%
EBIT Margin	20.03%
FCF Margin	13.29%

Dividends & Yields

This stock pays an annual dividend of 3.92, which amounts to a dividend yield of 3.78%.

Dividend Per Share	3.92
Dividend Yield	3.78%
Dividend Growth (YoY)	5.62%
Years of Dividend Growth	1
Payout Ratio	84.60%
Buyback Yield	0.02%
Shareholder Yield	3.81%
Earnings Yield	4.26%
FCF Yield	4.51%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a